drugset / Trial / NCT00537238

Pregabalin Versus Levetiracetam In Partial Seizures

NCT00537238

Phase 3 Completed 509 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will compare pregabalin and levetiracetam in patients with partial seizures. It will also evaluate the safety and tolerability of pregabalin and levetiracetam in these patients.

Timeline

Start
2007-10
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levetiracetam Other / unclassified 1000 mg Oral
Comparator Levetiracetam Other / unclassified 2000 mg Oral
Comparator Levetiracetam Other / unclassified 3000 mg Oral
Comparator Pregabalin Small molecule 300 mg Oral
Comparator Pregabalin Small molecule 450 mg Oral
Comparator Pregabalin Small molecule 600 mg Oral

Indications